Skip to main content

Advertisement

SpringerLink
Log in

Planning primary prevention of coronary disease

  • Published:
Current Atherosclerosis Reports Aims and scope Submit manuscript

Abstract

Effective prevention of the current annual $400 billion losses from atherosclerosis and cardiovascular disease (CVD) will require preventing primary causes rather than just decreasing signs and symptoms (risk factors) produced by those causes. All CVD risk factors predict a likelihood of CVD, but not all are causes of CVD. As a result, reducing some health risk assessment biomarkers may not appreciably reduce CVD and death. Careful review of molecular events connecting diets to death identifies two modifiable food imbalances that cause major chronic diseases in Americans. They are 1) imbalance between ingestion and expenditure of food energy, and 2) imbalance between omega-3 and omega-6 essential fatty acid levels in ingested foods. Health insurers could reduce costs and revolutionize preventive health care by monitoring omega-3 and omega-6 proportions in blood fatty acids and by using personalized interactive food choice software to adjust food intakes to fit individual preferences.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Centers for Disease Control and Prevention: About Heart Disease and Stroke Prevention at CDC. Available at http://www.cdc.gov/DHDSP/about_program.htm. Accessed January 15, 2009.

  2. AHA Statistics Committee and Stroke Statistics Subcommittee: Heart Disease and Stroke Statistics—2009 Update. Circulation 2009 (in press).

  3. De Gruttola VG, Clax P, DeMets DL, et al.: Considerations in the Evaluation of Surrogate Endpoints in Clinical Trials: Summary of a National Institutes of Health Workshop. Control Clin Trials 2001, 22:485–502.

    Article  PubMed  Google Scholar 

  4. Lands WE: Primary prevention in cardiovascular disease: moving out of the shadows of the truth about death. Nutr Metab Cardiovasc Dis 2003, 13:154–164.

    Article  PubMed  CAS  Google Scholar 

  5. Lands B: A critique of paradoxes in current advice on dietary lipids. Prog Lipid Res 2008, 47:77–106.

    Article  PubMed  CAS  Google Scholar 

  6. Steinberg D: Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy. Part IV: The 1984 coronary primary prevention trial ends it—almost. J Lipid Res 2006, 47:1–14.

    Article  PubMed  CAS  Google Scholar 

  7. Consensus conference: Lowering blood cholesterol to prevent heart disease. JAMA 1985, 253:2080–2086.

  8. Wang CY, Liu PY, Liao JK: Pleiotropic effects of statin therapy: molecular mechanisms and clinical results. Trends Mol Med 2008, 14:37–44.

    Article  PubMed  CAS  Google Scholar 

  9. Liu PY, Liu YW, Lin LJ, et al.: Evidence for statin pleiotropy in humans. differential effects of statins and ezetimibe on Rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation. Circulation 2008 Dec 15 [Epub ahead of print].

  10. Shi H, Kokoeva MV, Inouye K, et al.: TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest 2006, 116:3015–3025.

    Article  PubMed  CAS  Google Scholar 

  11. Kim F, Pham M, Maloney E, et al.: Vascular inflammation, insulin resistance, and reduced nitric oxide production precede the onset of peripheral insulin resistance. Arterioscler Thromb Vasc Biol 2008, 28:1982–1988.

    Article  PubMed  CAS  Google Scholar 

  12. Zieske AW, Malcom GT, Strong JP: Natural history and risk factors of atherosclerosis in children and youth: the PDAY study. Pediatr Pathol Mol Med 2002, 21:213–237.

    Article  PubMed  Google Scholar 

  13. Lands WE, Libelt B, Morris A, et al.: Maintenance of lower proportions of n-6 eicosanoid precursors in phospholipids of human plasma in response to added dietary n-3 fatty acids. Biochem Biophys Acta 1992, 1180:147–162.

    PubMed  CAS  Google Scholar 

  14. Lands WE: Diets could prevent many diseases. Lipids 2003, 18:317–321.

    Article  Google Scholar 

  15. Studer M, Briel M, Leimenstoll B, et al.: Effect of different antilipidemic agents and diets on mortality: a systematic review. Arch Intern Med 2005, 165:725–730.

    Article  PubMed  CAS  Google Scholar 

  16. Krumholz HM, Lee TH: Redefining quality—implications of recent clinical trials. N Engl J Med 2008, 358:2537–2539.

    Article  PubMed  CAS  Google Scholar 

  17. Birtwhistle R: What ever happened to the Mediterranean diet? QJM 2008, 101:741–742.

    Article  PubMed  CAS  Google Scholar 

  18. Kastelein JJ, Akdim F, Stroes ES, et al.; ENHANCE Investigators: Simvastatin with or without ezetimibe in familial hypercholesterolemia. N Engl J Med 2008, 358:1431–1443.

    Article  PubMed  CAS  Google Scholar 

  19. Carey J: Do cholesterol drugs do any good? Available at http://www.businessweek.com/magazine/content/08_04/b4068052092994.htm. Accessed on January 12, 2009.

  20. Couzin J: Cholesterol veers off script. Science 2008, 322:220–223.

    Article  PubMed  CAS  Google Scholar 

  21. Hoogwerf BJ; Action to Control Cardiovascular Risk in Diabetes Study Group: Does intensive therapy of type 2 diabetes help or harm? Seeking accord on ACCORD. Cleve Clin J Med 2008, 75:729–737.

    Article  PubMed  Google Scholar 

  22. Ridker PM, Danielson E, Fonseca FA, et al.; JUPITER Study Group: Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med 2008, 359:2195–2207.

    Article  PubMed  CAS  Google Scholar 

  23. Carey J: Heart disease: Not about cholesterol? Available at http://www.businessweek.com/bwdaily/dnflash/content/apr2008/db20080414_688906.htm. Accessed on January 12, 2009.

  24. Tsitouras PD, Gucciardo F, Salbe AD, et al.: High omega-3 fat intake improves insulin sensitivity and reduces CRP and IL6, but does not affect other endocrine axes in healthy older adults. Horm Metab Res 2008, 40:199–205.

    Article  PubMed  CAS  Google Scholar 

  25. Gissi-HF Investigators: Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1223–1230.

    Article  CAS  Google Scholar 

  26. Gissi-HF Investigators: Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet 2008, 372:1231–1239.

    Article  CAS  Google Scholar 

  27. Lands WE: Dietary fat and health: the evidence and the politics of prevention: careful use of dietary fats can improve life and prevent disease. Ann N Y Acad Sci 2005, 1055:179–192.

    Article  PubMed  CAS  Google Scholar 

  28. Kirihara Y, Hamazaki K, Hamazaki T, et al.: The relationship between total blood cholesterol levels and all-cause mortality in Fukui City, and meta-analysis of this relationship in Japan [in Japanese]. Shishitsu-Eiyogaku (J Lipid Nutr) 2008, 17:67–78.

    Article  CAS  Google Scholar 

  29. Verschuren WM, Jacobs DR, Bloemberg BP, et al.: Serum total cholesterol and long-term coronary heart disease mortality in different cultures. Twenty-five year follow-up of the seven countries study. JAMA 1995, 274:131–136.

    Article  PubMed  CAS  Google Scholar 

  30. Lands WE: Functional foods in primary prevention or nutraceuticals in secondary prevention? Curr Top Nutraceut Res 2003, 1:113–120.

    CAS  Google Scholar 

  31. Stark KD: The percentage of n-3 highly unsaturated fatty acids in total HUFA as a biomarker for omega-3 fatty acid status in tissues. Lipids 2008, 43:45–53.

    Article  PubMed  CAS  Google Scholar 

  32. Ohta A, Mayo MC, Kramer N, Lands WE: Rapid analysis of fatty acids in plasma lipids. Lipids 1990, 25:742–747.

    Article  PubMed  CAS  Google Scholar 

  33. Marangoni F, Colombo C, Galli C: A method for the direct evaluation of the fatty acid status in a drop of blood from a fingertip in humans: applicability to nutritional and epidemiological studies. Anal Biochem 2004, 326:267–272.

    Article  PubMed  CAS  Google Scholar 

  34. Armstrong JM, Metherel AH, Stark KD: Direct microwave transesterification of fingertip prick blood samples for fatty acid determinations. Lipids 2008, 43:187–196.

    Article  PubMed  CAS  Google Scholar 

  35. Masood MA, Salem N Jr: High throughput analysis of plasma fatty acid methyl esters employing robotic transesterification and fast gas chromatography. Lipids 2008, 43:171–180.

    Article  PubMed  CAS  Google Scholar 

  36. Lee TH, Mencia-Huerta JM, Shih C, et al.: Effects of exogenous arachidonic, eicosapentaenoic, and docosahexaenoic acids on the generation of 5-lipoxygenase pathway products by ionophore-activated human neutrophils. J Clin Invest 1984, 74:1922–1933.

    Article  PubMed  CAS  Google Scholar 

  37. Wada M, DeLong CJ, Hong YH, et al.: Enzymes and receptors of prostaglandin pathways with arachidonic acidderived versus eicosapentaenoic acid-derived substrates and products. J Biol Chem 2007, 282:22254–22266.

    Article  PubMed  CAS  Google Scholar 

  38. Erkkilä AT, Lichtenstein AH, Mozaffarian D, Herrington DM: Fish intake is associated with a reduced progression of coronary artery atherosclerosis in postmenopausal women with coronary artery disease. Am J Clin Nutr 2004, 80:626–632.

    PubMed  Google Scholar 

  39. Harris WS, Kris-Etherton PM, Harris KA: Intakes of longchain omega-3 fatty acid associated with reduced risk for death from coronary heart disease in healthy adults. Curr Atheroscler Rep 2008, 10:503–509.

    Article  PubMed  CAS  Google Scholar 

  40. Virtanen JK, Siscovick DS, Longstreth WT Jr, et al.: Fish consumption and risk of subclinical brain abnormalities on MRI in older adults. Neurology 2008, 71:439–446.

    Article  PubMed  CAS  Google Scholar 

  41. Lichtenstein AH, Appel LJ, Brands M, et al.: Summary of American Heart Association Diet and Lifestyle Recommendations revision 2006. Arterioscler Thromb Vasc Biol 2006, 26:2186–2191.

    Article  PubMed  CAS  Google Scholar 

  42. Healy B: From Fish Oil to Medicine: No nutrient is more important for decreasing cardio-vascular death—and more lacking—than omega-3. Available at http://health.usnews.com/articles/health/heart/2008/08/07/from-fish-oil-tomedicine_print.htm. Accessed on January 16, 2009.

  43. Block RC, Harris WS, Reid KJ, et al.: EPA and DHA in blood cell membranes from acute coronary syndrome patients and controls. Atherosclerosis 2008, 197:821–828.

    Article  PubMed  CAS  Google Scholar 

  44. Siscovick DS, Raghunathan TE, King I, et al.: Dietary intake and cell membrane levels of long-chain n-3 polyunsaturated fatty acids and the risk of primary cardiac arrest. JAMA 1995, 274:1363–1367.

    Article  PubMed  CAS  Google Scholar 

  45. Erkkilä AT, Matthan NR, Herrington DM, Lichtenstein AH: Higher plasma docosahexaenoic acid is associated with reduced progression of coronary atherosclerosis in women with CAD. J Lipid Res 2006, 47:2814–2819.

    Article  PubMed  CAS  Google Scholar 

  46. Harris WS, Reid KJ, Sands SA, Spertus JA: Blood omega-3 and trans fatty acids in middle-aged acute coronary syndrome patients. Am J Cardiol 2007, 99:154–158.

    Article  PubMed  CAS  Google Scholar 

  47. Aarsetøy H, Pönitz V, Nilsen OB, et al.: Low levels of cellular omega-3 increase the risk of ventricular fibrillation during the acute ischaemic phase of a myocardial infarction. Resuscitation 2008, 78:258–264.

    Article  PubMed  CAS  Google Scholar 

  48. Mohrhauer H, Holman RT: The effect of dose level of essential fatty acids upon fatty acid composition of the rat liver. J Lipid Res 1963, 4:151–159.

    PubMed  CAS  Google Scholar 

  49. Liou YA, King DJ, Zibrik D, Innis SM: Decreasing linoleic acid with constant alpha-linolenic acid in dietary fats increases (n-3) eicosapentaenoic acid in plasma phospholipids in healthy men. J Nutr 2007, 137:945–952.

    PubMed  CAS  Google Scholar 

  50. Freeman MP, Hibbeln JR, Wisner KL, et al.: Omega-3 fatty acids: evidence basis for treatment and future research in psychiatry. J Clin Psychiatry 2006, 67:1954–1967.

    Article  PubMed  CAS  Google Scholar 

  51. Amin AA, Menon RA, Reid KJ, et al.: Acute coronary syndrome patients with depression have low blood cell membrane omega-3 fatty acid levels. Psychosom Med 2008, 70:856–862.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. 6100 Westchester Park Drive, College Park, MD, 20740, USA

    Bill Lands

Authors
  1. Bill Lands
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Bill Lands.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lands, B. Planning primary prevention of coronary disease. Curr Atheroscler Rep 11, 272–280 (2009). https://doi.org/10.1007/s11883-009-0042-6

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11883-009-0042-6

Keywords

Search

Navigation